Enlightening innovation

It’s in our very cells

At Ideeea Therapeutics, we are a biotech powerhouse committed to developing, co-creating and manufacturing groundbreaking, ready-to-use Advanced Therapy Medicinal Products (ATMPs) in the fields of regenerative and autoimmune medicine.

Our vision

By enlightening advanced therapies, we enlighten hope

We aspire to be a leading biotech powerhouse in ATMP development, pushing boundaries in autoimmune, inflammatory and regenerative diseases, enlightening the future of health to improve patient’s lives.

Our name "ideeea" embodies the essence of what we do: turning groundbreaking ideas into advanced therapies, through open innovation, bringing hope to patients in need.

Meet the team who is bringing new light to advanced therapies

Ideeea Therapeutics was founded in 2020 by a team of healthcare executives from FARMALIDER, a leading Spanish pharmaceutical company with a strong track record in developing Rx, OTC and innovative products for the global B2B market.

Together, we aim to develop disruptive cell therapies using allogeneic cells for complex and medical conditions with limited therapeutic options. The founders’ goal is to offer treatments that are scalable and accesible to millions of patients worldwide.